Browse Category

NYSE:PRGO News 5 November 2025

Perrigo (PRGO) Stock Plunges to 52-Week Low as Outlook Slashed – What Investors Need to Know

Perrigo (PRGO) Stock Plunges to 52-Week Low as Outlook Slashed – What Investors Need to Know

Company Overview: A Self-Care Healthcare Player Perrigo Company plc is a consumer healthcare and self-care products company with over a century of history in the OTC medicine space Perrigo. Now domiciled in Dublin, Ireland (with major operations in the U.S. and Europe), Perrigo’s business spans a broad range of non-prescription health products. The company produces store-brand OTC medicines (the kind sold under retailers’ brands) as well as its own branded products in categories like cough & cold remedies, pain relief, digestive health, vitamins, infant formula, and dermatology care Patsnap Patsnap. Perrigo’s unique business model leverages its cash-generating store-brand portfolio to
5 November 2025

Stock Market Today

AT&T stock price: T slips after $6.5B bond sale as payrolls, CPI loom next week

AT&T stock price: T slips after $6.5B bond sale as payrolls, CPI loom next week

7 February 2026
AT&T shares closed down 0.7% at $27.13 on Friday, underperforming the S&P 500’s 1.97% gain. The company completed a $6.5 billion global notes sale this week, with maturities from 2031 to 2056 and coupons between 4.4% and 6%. Investors await delayed U.S. jobs and inflation data, along with T-Mobile’s upcoming earnings update.
GE Vernova stock price jumps toward $800 — what to know before Monday trade

GE Vernova stock price jumps toward $800 — what to know before Monday trade

7 February 2026
GE Vernova shares jumped 5.7% to $779.35 Friday after Baird upgraded the stock and the Dow closed above 50,000. The company’s onshore wind unit reported 1.1 GW in U.S. repower orders for 2025, a figure previously disclosed. GE Vernova also completed a $2.6 billion senior notes offering to help fund its Prolec GE stake purchase. Next earnings report is set for April 22.
Go toTop